Zofran | The American Association For Justice

Zofran

Litigation Packet: Document Details

Packet Name: Zofran

Updated Date: 7/1/2017 | Created Date: 5/1/2015 | Number of Pages: 3079
Summary of Packet:
  • Resources for attorneys investigating and filing cases for birth defects caused by Zofran, an anti-nausea medication approved for the treatment of chemotherapy related nausea but prescribed off label to pregnant women for the treatment of morning sickness and hyperemesis gravidarum
  • Zofran has been linked to heart defects, including septal ventricular and atrial defects, cleft lip, cleft palate, club foot, and skull deformities
  • Includes a sample complaint template and case screening information
  • Includes MDL case materials such as complaints, answers, motions, and orders
  • AAJ Education speaker papers, drug information from the FDA, and a bibliography of related medical journal articles
Access to the AAJ Exchange and Litigation Packets is restricted to plaintiff attorneys who are AAJ Regular, Sustaining, Life, Presidents Club, or Leaders Forum members.